A team led by investigators at Massachusetts General Hospital (MGH) has overcome a major constraint for cutting and editing DNA by CRISPR-Cas enzymes and other technologies. The recent innovation, which is published in Nature ...
Biotechnology
Oct 11, 2022
0
60
Li Dong's group from the Institute of Biophysics of the Chinese Academy of Science, in collaboration with DAI Qionghai's group from Department of Automation of Tsinghua University and Dr. Jennifer Lippincott-Schwartz from ...
Biotechnology
Oct 11, 2022
0
44
What exactly are the molecular interactions between the virus causing COVID-19 and its human host? How might our genetic differences cause different disease courses? And how do still-emerging virus variants differ in their ...
Biotechnology
Oct 10, 2022
0
101
Thanks to new RNA vaccines, we humans have been able to protect ourselves incredibly quickly from new viruses like SARS-CoV-2, the virus that causes COVID-19. These vaccines insert a piece of ephemeral genetic material into ...
Cell & Microbiology
Oct 5, 2022
0
46
Fluorescence imaging of biological samples stands to benefit greatly by a RIKEN discovery of a fluorescent protein derived from a Japanese jellyfish that maintains its brightness even when illuminated by strong light.
Biotechnology
Sep 30, 2022
0
39
Kidney disease affects one in nine adults globally and the incidence of kidney failure is steadily rising around the world. Being able to grow working kidney tissue in a laboratory could help accelerate medical treatments ...
Cell & Microbiology
Aug 30, 2022
0
116
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC San Francisco (UCSF), ...
Biotechnology
Aug 25, 2022
0
83
Circular ribonucleic acids (circRNAs) are a promising platform for gene expression studies as a stable and prevalent ribonucleic acid in eukaryotic cells, which arise from back-splicing. In a new report now published in Nature ...
A recent study published in Nature Biotechnology revealed the development of high-fidelity Cas13 variants with markedly reduced collateral effects by mutagenesis and demonstrated the feasibility of hfCas13 for efficient on-target ...
Biotechnology
Aug 12, 2022
0
11
When researchers working on the Human Genome Project completely mapped the genetic blueprint of humans in 2001, they were surprised to find only around 20,000 genes that produce proteins. Could it be that humans have only ...
Biotechnology
Jul 13, 2022
0
480
